Burleson & Co’s Amryt Pharma AMYT Stock Holding History
Bought
Maintained
Sold
Other funds holding AMYT
ACM
Burleson & Co's AMYT Position: Q4 2022 in Review
Burleson & Co held its Amryt Pharma (AMYT) position steady in Q4 2022 at 22 shares worth $161. The position accounts for ﹤0.01% of the portfolio, ranked #400.
Burleson & Co first reported a position in AMYT in Q1 2021 and has held it in 8 quarters since. 58 funds tracked by Wall St. Rank hold AMYT as of Q4 2022.
- Burleson & Co held 22 shares of Amryt Pharma worth $161 as of Q4 2022.
- Burleson & Co left its Amryt Pharma share count unchanged in Q4 2022.
- Amryt Pharma made up ﹤0.01% of Burleson & Co's portfolio in Q4 2022, its #400 holding.
- Burleson & Co first reported a position in Amryt Pharma in Q1 2021 and has held it in 8 quarters since.
- 58 funds tracked by Wall St. Rank held Amryt Pharma as of Q4 2022.
Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.